Search Results - "Stramer, S. L."

Current prevalence and incidence of infectious disease markers and estimated window-period risk in the American Red Cross blood donor population by Dodd, R.Y., Notari IV, E.P., Stramer, S.L.

“…BACKGROUND : There has been continuing prog‐ ress in measures to reduce the risk of transfusion‐ transmitted infection, including introduction of serologic…”
Get full text

The cost-effectiveness of NAT for HIV, HCV, and HBV in whole-blood donations by Jackson, B.R., Busch, M.P., Stramer, S.L., AuBuchon, J.P.

“…BACKGROUND: The risk of viral infection associated with blood transfusion is lower than ever before because of aggressive screening and testing practices. NAT…”
Get full text

Self-reported symptoms associated with West Nile virus infection in RNA-positive blood donors by Orton, S.L., Stramer, S.L., Dodd, R.Y.

“…BACKGROUND:  In 2003, West Nile virus (WNV) nucleic acid amplification testing (NAT) was implemented to detect potentially infected donors. Of more than 5.3…”
Get full text

Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004 by Stramer, S.L., Foster, G.A., Dodd, R.Y.

“…BACKGROUND:  This study reports on the efficacy of an investigational human T‐lymphotropic virus (HTLV)‐I and ‐II lookback program in the context of differing…”
Get full text

New Testing Strategy to Detect Early HIV-1 Infection for Use in Incidence Estimates and for Clinical and Prevention Purposes by Janssen, Robert S, Satten, Glen A, Stramer, Susan L, Rawal, Bhupat D, O'Brien, Thomas R, Weiblen, Barbara J, Hecht, Frederick M, Jack, Noreen, Cleghorn, Farley R, Kahn, James O, Chesney, Margaret A, Busch, Michael P

“…CONTEXT.— Differentiating individuals with early human immunodeficiency virus 1 (HIV-1) infection from those infected for longer periods is difficult but…”
Get full text

Risk factors for HCV infection among blood donors confirmed to be positive for the presence of HCV RNA and not reactive for the presence of anti-HCV by Orton, S.L., Stramer, S.L., Dodd, R.Y., Alter, M.J.

“…BACKGROUND: In 1999, NAT of blood donations was implemented to detect “window‐period” infections. Blood donors who have confirmed NAT results positive for the…”
Get full text

Infectious disease agents and their potential threat to transfusion safety (an update to the 2009 Transfusion supplement) by Katz, L. M., Dodd, Roger Y., Saa, Paula, Gorlin, J. B., Palmer, K., Hollinger, F. B., Stramer, S. L.

Get full text

In Vitro Evaluation of the Protective Role of Human Antibodies to West Nile Virus (WNV) Produced during Natural WNV Infection by Rios, M., Dayton, A. I., Wood, O., Hewlett, I. K., Epstein, J. S., Caglioti, S., Stramer, S. L.

“…Background. West Nile virus (WNV) is endemic in the United States and transmissible by transfusion. Since 2003, the US blood supply has been screened by…”
Get full text

Reacting to an emerging safety threat: West Nile virus in North America by Stramer, S L

“…West Nile virus (WNV) entered North America in 1999 and in 2002 was shown to be transfusion transmitted. With competent mosquito and bird vectors throughout…”
Get more information

Viral diagnostics in the arena of blood donor screening by Stramer, S. L.

Get full text

Trypanosoma cruzi screening in Texas blood donors, 2008–2012 by GARCIA, M. N., WOC-COLBURN, L., ROSSMANN, S. N., TOWNSEND, R. L., STRAMER, S. L., BRAVO, M., KAMEL, H., BEDDARD, R., TOWNSEND, M., OLDHAM, R., BOTTAZZI, M. E., HOTEZ, P. J., MURRAY, K. O.

“…Chagas disease is an important emerging disease in Texas that results in cardiomyopathy in about 30% of those infected with the parasite Trypanosoma cruzi…”
Get full text

Cytokine and Chemokine Responses in the Acute Phase of Hepatitis B Virus Replication in Naive and Previously Vaccinated Blood and Plasma Donors by Keating, Sheila M., Heitman, John D., Wu, Shiquan, Deng, Xutao, Stramer, Susan L., Kuhns, Mary C., Mullen, Carolyn, Norris, Philip J., Busch, Michael P.

“…Background. Blood and plasma donor screening for hepatitis virus (HBV) DNA, HBV surface antigen (HBsAg), and antibodies to surface (anti-HBs) and core…”
Get full text

Performance of ORTHO® HCV core antigen and trak-C™ assays for detection of viraemia in pre-seroconversion plasma and whole blood donors by Tobler, L. H., Stramer, S. L., Lee, S. R., Baggett, D., Wright, D., Hirschkorn, D., Walsh, I., Busch, M. P.

“…Objective  Logistics and cost of nucleic acid amplification testing (NAT) screening preclude its current use in many developing countries. Development of…”
Get full text

NAT update: where are we today? by Stramer, S L

“…The US blood supply has been tested for HIV-1 and HCV using Nucleic Acid Amplification Testing (NAT) of small pools since early in 1999. Since the…”
Get more information

Detection of HIV-1 and HCV Infections among Antibody-Negative Blood Donors by Nucleic Acid–Amplification Testing by Stramer, Susan L, Glynn, Simone A, Kleinman, Steven H, Strong, D. Michael, Caglioti, Sally, Wright, David J, Dodd, Roger Y, Busch, Michael P

“…Since 1999, nucleic acid–amplification testing has been used in the United States to identify units of blood from donors with viremia in the window period…”
Get full text

Transmission of West Nile Virus through Blood Transfusion in the United States in 2002 by Pealer, Lisa N, Marfin, Anthony A, Petersen, Lyle R, Lanciotti, Robert S, Page, Peter L, Stramer, Susan L, Stobierski, Mary Grace, Signs, Kimberly, Newman, Bruce, Kapoor, Hema, Goodman, Jesse L, Chamberland, Mary E

“…In 2002, 23 patients in the United States were confirmed to have acquired the West Nile virus through the transfusion of red cells, platelets, or plasma. Most…”
Get full text

Sensitivity and specificity of human T-lymphotropic virus (HTLV) types I and II polymerase chain reaction and several serologic assays in screening a population with a high prevalence of HTLV-II by Liu, H., Shah, M., Stramer, S.L., Chen, W., Weiblen, B.J., Murphy, E.L.

“…BACKGROUND: Since 1988, all blood donations in the United States have been screened for antibodies to human T‐lymphotropic virus type I (HTLV‐I). However, the…”
Get full text

Lookback on donors who are repeatedly reactive on first-generation hepatitis C virus assays : justification and rational implementation by TOBLER, L. H, TEGTMEIER, G, STRAMER, S. L, QUAN, S, DOCKTER, J, GIACHETTI, C, BUSCH, M. P

“…The purpose of this study was to explore strategies to minimize the number of unwarranted consignee notifications resulting from hepatitis C virus (HCV)…”
Get full text

Probability of Viremia with HBV, HCV, HIV, and HTLV among Tissue Donors in the United States by Zou, Shimian, Dodd, Roger Y, Stramer, Susan L, Strong, D. Michael

“…In this study, on the basis of data on 11,391 tissue donors, the probability of undetected viremia with the human immunodeficiency virus, hepatitis B virus,…”
Get full text

Early detection of antibody to human immunodeficiency virus type 1 by using an antigen conjugate immunoassay correlates with the presence of immunoglobulin M antibody by GALLARDA, J. L, HENRARD, D. R, LIU, D, HARRINGTON, S, STRAMER, S. L, VALINSKY, J. E, PING WU

“…Article Usage Stats Services JCM Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
Get full text